{'fraction_non_alphanumeric': 0.024390243902439025, 'fraction_numerical': 0.0, 'mean_word_length': 5.433734939759036, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The periprocedural management of oral anticoagulation in atrial fibrillation ablation: is it really clear which is the best approach?

Nowadays, the atrial fibrillation ablation is a safe procedure with a low incidence of major complications. In this setting, the direct oral anticoagulants (DOACs) have been proven to be safer and more effective compared with vitamin K antagonists (VKAs) and, thanks to their advantages in terms of shorter half-life and more targeted mechanism of anticoagulation, are widely and increasingly used.